SOCIETEX CORPORATE FINANCE advises the founding-managing director of the EMKA Group in the reorganization of its capital.

This BIMBO operation sets a new stage in the development of the Group. It allows SIPAREX to sell its minority stake in favor of BNP PARIBAS DEVELOPPEMENT and David Brunet. The founding-managing director Jean-Gérard Napoléoni remains majority shareholder.

Created by Jean-Gérard Napoléoni in 1992, the EMKA TECHNOLOGIES Group is a world leader in the design, manufacture and distribution of systems for preclinical cardiology, neurological and pulmonary research.

With an international team of 80 people, the Group, which generates close to € 10M sales, offers a comprehensive range of products, software and services for preclinical researchers (pharmaceutical companies, CROs and universities) through 5 entities in France, Canada, USA, China and Japan.

Since the acquisition in 2014 of SCIREQ, a Canadian company led by David Brunet, the group has been able to accelerate its development, particularly in the pulmonary segment.

To learn more

Bernard Maussion Bernard Maussion For any information
about this transaction
Send an email

For any further information,
please contact us right away

en bas